共 106 条
[1]
Bhattacharyya S(2018)Effect of cannabidiol on medial temporal, midbrain, and striatal dysfunction in people at clinical high risk of psychosis: a randomized clinical trial JAMA Psychiat 75 1107-1117
[2]
WilsonR A-KE(2007)Psychiatric issues in multiple sclerosis Psychiatr Clin North Am 30 803-817
[3]
O’Neill A(2016)Nonmedical prescribing: where are we now? Therapeutic Adv Drug Safety 7 165-172
[4]
Brammer M(2019)Cannabidiol as a potential treatment for psychosis Therapeutic Adv Psychopharmacol 9 1-16
[5]
Perez J(2014)Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders Epilepsia. 55 791-802
[6]
Murray R(2009)High-potency cannabis and the risk of psychosis Br J Psychiatry 195 488-491
[7]
Allen P(2019)Medicinal use of cannabis based products and cannabinoids BMJ 2019 184-191
[8]
Bossong MG(2012)Epilepsy, suicidality, and psychiatric disorders: a bidirectional association Ann Neurol 72 139-154
[9]
McGuire P(2017)An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies Cannabis Cannabinoid Res 2 80-85
[10]
Chwastiak L(2019)Survey of Australian psychiatrists and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids Australasian Psychiatry 27 4790-4805